Psoriasis trials in Netherlands
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune mediated diseases.
- Where
- Leiden
- Age
- 18 years to 64 years
- People
- 182
- Run by
- Klear Bio Inc.
See details and how to join2026-525575-22-00 · EU 2026-525575-22-00 - No phaseNot yet taking people in NetherlandsSkin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin Diseases
- Where
- Almelo, Enschede, Hengelo
- Age
- 16 years and over
- People
- 1,000
- Run by
- Medisch Spectrum Twente
See details and how to joinNCT07804134 - Phase 1Taking peopleA Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period
- Where
- Leiden
- Age
- 18 years to 60 years
- People
- 32
- Run by
- Zealand Pharma
See details and how to joinNCT07733089 · EU 2026-525220-15-00 - Phase 4Taking peopleREDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
- Where
- Amsterdam, Enschede, Harderwijk, Maastricht, Nijmegen, Rotterdam, Tilburg, Ubbergen, Uden, Zwolle
- Age
- 16 years and over
- People
- 200
- Run by
- Sint Maartenskliniek
See details and how to joinNCT07160231 · EU 2025-520757-36-00 - No phaseTaking peopleSKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 840
- Run by
- Leiden University Medical Center
See details and how to joinNCT07021495 - No phaseNot yet taking people in NetherlandsIs Monitoring Enhanced Auto-fluorescence Beneficial for the Precise Removal of Tissue From Psoriatic Lesions With Ablative Lasers?
- Where
- Hilversum
- Age
- 18 years to 64 years
- People
- 47
- Run by
- Nick van der Beek
See details and how to joinNCT07130019 - Phase 1Taking peopleQuantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
- Where
- Groningen
- Age
- 18 years and over
- People
- 56
- Run by
- University Medical Center Groningen
See details and how to joinNCT05725876 · EU 2023-506192-10-00 - Phase 2Taking people[18F]Fluoride PET-CT in psoriasis patients at risk for developing psoriatic arthritis
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 15
- Run by
- Stichting Amsterdam UMC
See details and how to join2024-514759-13-01 · EU 2024-514759-13-01